143 related articles for article (PubMed ID: 1685572)
1. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
[TBL] [Abstract][Full Text] [Related]
2. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
Pflug B; Bartels M; Bauer H; Bunse J; Gallhofer B; Haas S; Kanzow WT; Klieser E; Küfferle B; Stein D
Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475
[TBL] [Abstract][Full Text] [Related]
3. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
den Boer JA; Westenberg HG
Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
[TBL] [Abstract][Full Text] [Related]
4. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
Laux G; Klieser E; Schröder HG; Dittmann V; Unterweger B; Schubert H; König P; Schöny HW; Bunse J; Beckmann H
Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
Mendlewicz J; de Bleeker E; Cosyns P; Deleu G; Lotstra F; Masson A; Mertens C; Parent M; Peuskens J; Suy E
Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
[TBL] [Abstract][Full Text] [Related]
7. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Andersen J; Kørner A; Ostergaard P; Fensbo C; Birket-Smith M; Thiesen S; Hansen NR; Fogh M; Kristensen M; Møller-Nielsen EM
Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
Widerlöv E; Franzén G; Jansson P; Movin G
Int Clin Psychopharmacol; 1990 Apr; 5(2):125-34. PubMed ID: 1974271
[TBL] [Abstract][Full Text] [Related]
9. Once-daily controlled release remoxipride is equieffective with twice-daily immediate release remoxipride in the treatment of schizophrenia.
Alexander MS; Chakravarti SK; Sundararajan K; Mullin JM; Shaw SH; Blomqvist M; Lockett CM
J Psychopharmacol; 1993 Jan; 7(3):276-82. PubMed ID: 22290842
[TBL] [Abstract][Full Text] [Related]
10. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
[TBL] [Abstract][Full Text] [Related]
12. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
[TBL] [Abstract][Full Text] [Related]
13. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A
Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
[TBL] [Abstract][Full Text] [Related]
14. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
Patris M; Agussol P; Alby JM; Brion S; Burnat G; Castelnau D; Deluermoz S; Dufour H; Ferreri M; Goudemand M
Acta Psychiatr Scand Suppl; 1990; 358():78-82. PubMed ID: 1978497
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
Lewander T; Westerbergh SE; Morrison D
Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
[TBL] [Abstract][Full Text] [Related]
16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia.
Tench D; Soni SD; Ashwood T; Movin G
Psychopharmacology (Berl); 1990; 101(1):132-6. PubMed ID: 1971445
[TBL] [Abstract][Full Text] [Related]
18. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
20. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
